Ardevora Asset Management LLP Penumbra Inc Transaction History

Ardevora Asset Management LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 22, 2021	SELL	$175.6 - $291.43 $44.7 Million - $74.2 Million	-254,470 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$174.98 - $272.83 $3.6 Million - $5.62 Million	-20,600 Reduced 7.49%	254,470 $44.5 Million
Q3 2020 Nov 05, 2020	SELL	$185.27 - $238.73 $518,756 - $668,444	-2,800 Reduced 1.01%	275,070 $53.5 Million
Q2 2020 Jul 28, 2020	SELL	$153.32 - $191.72 $1.98 Million - $2.48 Million	-12,930 Reduced 4.45%	277,870 $49.7 Million
Q1 2020 Apr 28, 2020	BUY	$124.34 - $193.76 $2.25 Million - $3.51 Million	18,100 Added 6.64%	290,800 $46.9 Million
Q4 2019 Feb 05, 2020	BUY	$134.81 - $177.8 $4.04 Million - $5.33 Million	30,000 Added 12.36%	272,700 $44.8 Million
Q3 2019 Oct 25, 2019	BUY	$131.82 - $183.4 $2.25 Million - $3.14 Million	17,100 Added 7.58%	242,700 $32.6 Million
Q2 2019 Aug 01, 2019	BUY	$124.65 - $167.39 $28.1 Million - $37.8 Million	225,600 New	225,600 $36.1 Million

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $8.98B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Ardevora Asset Management LLP with notifications on news.